BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20019669)

  • 1. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression.
    Chan MC; Hilyard AC; Wu C; Davis BN; Hill NS; Lal A; Lieberman J; Lagna G; Hata A
    EMBO J; 2010 Feb; 29(3):559-73. PubMed ID: 20019669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation.
    Martin-Garrido A; Williams HC; Lee M; Seidel-Rogol B; Ci X; Dong JT; Lassègue B; Martín AS; Griendling KK
    PLoS One; 2013; 8(11):e79657. PubMed ID: 24236150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
    Chen S; Liu B; Kong D; Li S; Li C; Wang H; Sun Y
    PLoS One; 2015; 10(4):e0122577. PubMed ID: 25874930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ; Yun YP
    Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
    Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
    Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L; Huangpu J; Karnovsky MJ
    Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.
    Graf K; Xi XP; Yang D; Fleck E; Hsueh WA; Law RE
    Hypertension; 1997 Jan; 29(1 Pt 2):334-9. PubMed ID: 9039124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB.
    Risinger GM; Updike DL; Bullen EC; Tomasek JJ; Howard EW
    Am J Physiol Cell Physiol; 2010 Jan; 298(1):C191-201. PubMed ID: 19846754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor BB modulates PCNA protein synthesis partially through the transforming growth factor beta signalling pathway in vascular smooth muscle cells.
    Pan D; Yang J; Lu F; Xu D; Zhou L; Shi A; Cao K
    Biochem Cell Biol; 2007 Oct; 85(5):606-15. PubMed ID: 17901902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype.
    Davis BN; Hilyard AC; Nguyen PH; Lagna G; Hata A
    J Biol Chem; 2009 Feb; 284(6):3728-38. PubMed ID: 19088079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells.
    Lo IC; Lin TM; Chou LH; Liu SL; Wu LW; Shi GY; Wu HL; Jiang MJ
    Cardiovasc Res; 2009 Mar; 81(4):771-9. PubMed ID: 19091791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,4',5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle.
    Xu XL; Huang YJ; Wang YQ; Chen XF; Zhang W
    Clin Exp Pharmacol Physiol; 2011 May; 38(5):307-13. PubMed ID: 21348889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
    Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
    Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-142-3p Is a Regulator of the TGFβ-Mediated Vascular Smooth Muscle Cell Phenotype.
    Kim K; Yang DK; Kim S; Kang H
    J Cell Biochem; 2015 Oct; 116(10):2325-33. PubMed ID: 25832008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.
    Porsch H; Mehić M; Olofsson B; Heldin P; Heldin CH
    J Biol Chem; 2014 Jul; 289(28):19747-57. PubMed ID: 24860093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogenic factors promoting intestinal smooth muscle cell proliferation.
    Stanzel RD; Lourenssen S; Nair DG; Blennerhassett MG
    Am J Physiol Cell Physiol; 2010 Oct; 299(4):C805-17. PubMed ID: 20631246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet-derived growth factor receptor/STAT3 signaling pathway regulates the phenotypic transition of corpus cavernosum smooth muscle in rats.
    Yan JF; Huang WJ; Zhao JF; Fu HY; Zhang GY; Huang XJ; Lv BD
    PLoS One; 2017; 12(2):e0172191. PubMed ID: 28245285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.